×

Case Studies

Validation of the CureMatch Approach

CureMatch Correctly Ranks Therapy that Led to Extraordinary Response in Metastatic Breast Cancer Patient

Breast CancerCombination TherapyDNA Sequencing
CureMatch Correctly Ranks Therapy that Led to Extraordinary Response in Metastatic Breast Cancer Patient

In this case study, a retrospective analysis was performed using data from a metastatic breast cancer patient. The patient was given five lines of treatment; the first four quickly failed and the fifth was highly successful. The analysis shows that CureMatch can correctly rank the efficacy of treatment options, and illustrates multiple benefits of using the CureMatch analysis.

Read More

In Vitro Study Demonstrates the Benefit of Personalized Combination Therapy

CancerCancer Cell LinesPersonalized Combination Therapy
In Vitro Study Demonstrates the Benefit of Personalized Combination Therapy

An in vitro study was performed that illustrates the benefit of CureMatch’s personalized combination therapy approach. The experiment used cancer cell lines that were derived from the tumors of patients. In the study, CureMatch used cell lines from human pancreatic adenocarcinoma tumors with eight mutations, two of which were deemed “actionable” – meaning that the CureMatch platform determined that […]

Read More

© 2023 CureMatch, Inc. CureMatch is a registered trademark.
Terms of Use | Privacy Policy | HIPAA Notice